New Therapies in the Treatment of High Cholesterol: An Argument to Return to Goal-Based Lipid Guidelines

JAMA. 2015 Oct 13;314(14):1443-4. doi: 10.1001/jama.2015.10017.
No abstract available

MeSH terms

  • Cholesterol, LDL / blood*
  • Drug Costs
  • Europe
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hyperlipidemias / blood
  • Hyperlipidemias / drug therapy*
  • Hypolipidemic Agents / economics
  • Hypolipidemic Agents / therapeutic use*
  • Practice Guidelines as Topic*
  • Proprotein Convertase 9
  • Proprotein Convertases / antagonists & inhibitors*
  • Serine Endopeptidases
  • United States

Substances

  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • PCSK9 protein, human
  • Proprotein Convertase 9
  • Proprotein Convertases
  • Serine Endopeptidases